Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria
Background. Although the association between lipoatrophy and highly active antiretroviral therapy (HAART) is well known, other nondrug factors may be associated with lipoatrophy in people living with HIV/AIDS (PLWHA). There are no reports of lipoatrophy from Nigeria, a country with the second larges...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | AIDS Research and Treatment |
| Online Access: | http://dx.doi.org/10.1155/2015/402638 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850167673858555904 |
|---|---|
| author | Sandra Omozehio Iwuala Olufunmilayo A. Lesi Olufemi Adetola Fasanmade Anas A. Sabir Michael Adeyemi Olamoyegun Charles C. Okany |
| author_facet | Sandra Omozehio Iwuala Olufunmilayo A. Lesi Olufemi Adetola Fasanmade Anas A. Sabir Michael Adeyemi Olamoyegun Charles C. Okany |
| author_sort | Sandra Omozehio Iwuala |
| collection | DOAJ |
| description | Background. Although the association between lipoatrophy and highly active antiretroviral therapy (HAART) is well known, other nondrug factors may be associated with lipoatrophy in people living with HIV/AIDS (PLWHA). There are no reports of lipoatrophy from Nigeria, a country with the second largest number of PLWHA. We aimed to determine the prevalence, characteristics, and factors associated with lipoatrophy in a cohort of patients attending the HIV clinic in Lagos University Teaching Hospital, Nigeria. Methods. Two hundred and eighty-eight patients with HIV infection were recruited for the study. The study protocol involved administration of a questionnaire, targeted physical examination (including anthropometric indices and skin fold thickness), and bioelectrical impedance analysis measurements. Lipoatrophy was defined clinically. Results. Lipoatrophy was present in 75 (26.0%) persons. It was associated with lower body circumferences, skin fold thicknesses, and lower % body fat with preservation of skeletal muscle mass (all P<0.05). Male gender and HAART use were the factors associated with lipoatrophy on multivariate analysis (P<0.05). Conclusion. Lipoatrophy is frequently encountered in patients with HIV infection in Nigeria, with HAART use conferring an added factor in its development. There is need for more physician and patient awareness of this condition. |
| format | Article |
| id | doaj-art-e750a511c21249328febe2dfafe9149e |
| institution | OA Journals |
| issn | 2090-1240 2090-1259 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | AIDS Research and Treatment |
| spelling | doaj-art-e750a511c21249328febe2dfafe9149e2025-08-20T02:21:09ZengWileyAIDS Research and Treatment2090-12402090-12592015-01-01201510.1155/2015/402638402638Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in NigeriaSandra Omozehio Iwuala0Olufunmilayo A. Lesi1Olufemi Adetola Fasanmade2Anas A. Sabir3Michael Adeyemi Olamoyegun4Charles C. Okany5Department of Medicine, College of Medicine University of Lagos, PMB 12003, Lagos, NigeriaDepartment of Medicine, College of Medicine University of Lagos, PMB 12003, Lagos, NigeriaDepartment of Medicine, College of Medicine University of Lagos, PMB 12003, Lagos, NigeriaDepartment of Medicine, Usmanu Danfodiyo University Teaching Hospital, PMB 2370, Sokoto, NigeriaDepartment of Medicine, LAUTECH Teaching Hospital and College of Health Sciences, Ladoke Akintola University of Technology, PMB 4007, Ogbomoso, Oyo State, NigeriaDepartment of Haematology and Blood Transfusion, Lagos University Teaching Hospital, PMB 12003, Lagos, NigeriaBackground. Although the association between lipoatrophy and highly active antiretroviral therapy (HAART) is well known, other nondrug factors may be associated with lipoatrophy in people living with HIV/AIDS (PLWHA). There are no reports of lipoatrophy from Nigeria, a country with the second largest number of PLWHA. We aimed to determine the prevalence, characteristics, and factors associated with lipoatrophy in a cohort of patients attending the HIV clinic in Lagos University Teaching Hospital, Nigeria. Methods. Two hundred and eighty-eight patients with HIV infection were recruited for the study. The study protocol involved administration of a questionnaire, targeted physical examination (including anthropometric indices and skin fold thickness), and bioelectrical impedance analysis measurements. Lipoatrophy was defined clinically. Results. Lipoatrophy was present in 75 (26.0%) persons. It was associated with lower body circumferences, skin fold thicknesses, and lower % body fat with preservation of skeletal muscle mass (all P<0.05). Male gender and HAART use were the factors associated with lipoatrophy on multivariate analysis (P<0.05). Conclusion. Lipoatrophy is frequently encountered in patients with HIV infection in Nigeria, with HAART use conferring an added factor in its development. There is need for more physician and patient awareness of this condition.http://dx.doi.org/10.1155/2015/402638 |
| spellingShingle | Sandra Omozehio Iwuala Olufunmilayo A. Lesi Olufemi Adetola Fasanmade Anas A. Sabir Michael Adeyemi Olamoyegun Charles C. Okany Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria AIDS Research and Treatment |
| title | Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria |
| title_full | Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria |
| title_fullStr | Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria |
| title_full_unstemmed | Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria |
| title_short | Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria |
| title_sort | prevalence of and risk factors for lipoatrophy in patients with hiv infection in nigeria |
| url | http://dx.doi.org/10.1155/2015/402638 |
| work_keys_str_mv | AT sandraomozehioiwuala prevalenceofandriskfactorsforlipoatrophyinpatientswithhivinfectioninnigeria AT olufunmilayoalesi prevalenceofandriskfactorsforlipoatrophyinpatientswithhivinfectioninnigeria AT olufemiadetolafasanmade prevalenceofandriskfactorsforlipoatrophyinpatientswithhivinfectioninnigeria AT anasasabir prevalenceofandriskfactorsforlipoatrophyinpatientswithhivinfectioninnigeria AT michaeladeyemiolamoyegun prevalenceofandriskfactorsforlipoatrophyinpatientswithhivinfectioninnigeria AT charlescokany prevalenceofandriskfactorsforlipoatrophyinpatientswithhivinfectioninnigeria |